SEC Filing Summary: Tivic Health Systems, Inc. (TIVC)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Tivic Health Systems, Inc. on November 13, 2025. The registrant is a Delaware corporation with principal executive offices in Fremont, California, and its common stock trades on The Nasdaq Stock Market LLC under the symbol TIVC. The company identifies itself as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial results.
Material Changes and Events
Under Item 8.01 (Other Events), the Company reported the findings of a Clinical Optimization Study for its non-invasive vagus nerve stimulation device. The details of these findings are contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Guidance, Outlook, and Risks
The filing includes a standard Forward-Looking Statements disclaimer. It notes that statements regarding future results, performance, or achievements involve substantial risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including those set forth in other documents filed with the SEC. No specific financial guidance or numerical outlook was provided in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 13, 2025) for specific data points regarding the Clinical Optimization Study findings.
- Verify the clinical significance and regulatory implications of the non-invasive vagus nerve stimulation device results.
- Check subsequent filings for any updates on the company's financial position or capital requirements following this clinical announcement.